In 2009, Dr. Jones suffered from a sudden onset of debilitating autoimmune psoriatic arthritis. Although he continued to see patients, his condition prevented him from performing surgery. When conventional treatments failed to provide him with relief, he turned to stem cell therapy. Four months after receiving therapy, he was able to return to a normal surgery schedule and a life without pain. As a result, he is responsible for bringing a proprietary stem cell technology to the United States to start Celltex Therapeutics Corporation in 2011 with David Eller.
View more stem cell therapy testimonials
Celltex Therapeutics Corporation is a Houston-based biotechnology company founded in 2011 by David Eller and Dr. Stanley Jones, an internationally-recognized spine surgeon, to initiate breakthroughs in regenerative medicine through adult stem cells. Eller is a graduate of Texas A&M University, who served two terms as Chairman of the Board of Regents and also served as Chancellor of The Texas A&M University System for a short period. It was at Texas A&M University that his passion for bioscience took flight, leading him to establish the Institute of Biosciences and Technology during his six year term on the Texas A&M University System Board of Regents.
Celltex uses proprietary technology to isolate, multiply and store autologous, adult (one’s own) mesenchymal stem cells (MSCs) to be used for regenerative therapy in a number of conditions including vascular, autoimmune and degenerative diseases, which is why Sarah was a great candidate for stem cell therapy.
Find Out More
For more information about Celltex and the process of stem cell banking or to review some frequently asked questions about stem cell therapy, please visit the pages below:
If you would like to speak to a Celltex client services representative about banking your stem cells, please visit the Getting Started page or call (713) 590-1000.